טוען...
Activation of FXR pathway does not alter glial cell function
BACKGROUND: The nuclear receptor farnesoid-X-receptor (FXR; NR1H4) is expressed not only in the liver, gut, kidney and adipose tissue but also in the immune cells. FXR has been shown to confer protection in several animal models of inflammation, including experimental autoimmune encephalomyelitis (E...
שמור ב:
| הוצא לאור ב: | J Neuroinflammation |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5371249/ https://ncbi.nlm.nih.gov/pubmed/28351411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-017-0833-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|